Prostate Carcinoma — Trials

Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,176 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 230
Ph III recruiting: 20
Growth YoY: −2.6%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (184)

clinicaltrialsPublishedShowing 151–200 of 525 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04030559	Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects	terminated	Phase 2	11	University of California, DavisOTHER	1	May 14, 2026	clinicaltrials
NCT05413850	Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection	recruiting	Phase 1 / Phase 2	82	Blue Earth Therapeutics LtdINDUSTRY	5	May 14, 2026	clinicaltrials